Skip to main content
NIH funding notice RFA-MH-14-171

Eradication of HIV-1 from CNS Reservoirs: Implications for Therapeutics (R21)

Closed on September 17, 2013.

Posted
April 10, 2013
Close date
September 17, 2013
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $148,500 in first-year total cost, median $148,500.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 AARR-D (50)]1

Most frequent institutions

  1. KWAZULU-NATAL RESEARCH INSTITUTE TB-HIV1
Competing awards under RFA-MH-14-171 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Ongoing HIV replication as a CNS persistence mechanism in the face of cART1R21MH104220-01SIGAL, ALEXANDERKWAZULU-NATAL RESEARCH INSTITUTE TB-HIV$148,500ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.